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eoangiogenesis, T-Lymphocyte Infiltration,
nd Heat Shock Protein-60 Are Biological
allmarks of an Immunomediated Inflammatory
rocess in End-Stage Calcified Aortic Valve Stenosis
nnamaria Mazzone, MD,* Maria Carmela Epistolato, BSC,† Raffaele De Caterina, MD, PHD,†
imona Storti, BSC,‡ Simona Vittorini, PHD,* Silverio Sbrana, MD, PHD,* Jacopo Gianetti, MD, PHD,*
tefano Bevilacqua, MD,* Mattia Glauber, MD,* Andrea Biagini, MD,* Piero Tanganelli, MD†
assa, Siena, and Chieti, Italy
OBJECTIVES We investigated the main biomolecular features in the evolution of aortic stenosis, focusing
on advanced lesions.
BACKGROUND “Degenerative” aortic valve stenosis shares risk factors and inflammatory similarities with
atherosclerosis.
METHODS We compared nonrheumatic stenotic aortic valves from 26 patients undergoing surgical valve
replacement (group A) and 14 surgical control patients (group B). We performed semiquan-
titative histological and immunohistochemical analyses on valve leaflets to measure inflam-
mation, sclerosis, calcium, neoangiogenesis, and intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1) expression. We assessed heat shock protein
60 (hsp60) gene expression as an index of cellular stress and C-reactive protein, erythrocyte
sedimentation rate, and fibrinogen as systemic inflammatory markers.
RESULTS In group A valves, we found a prevalence of calcium nodules surrounded by activated
inflammatory infiltrates, neovessels, and abundant ICAM-1, VCAM-1, and hsp60 gene
expression. Specimens from group B were negative for all of these markers, except 2 of 14
positivity for hsp60. The presence of active inflammatory infiltrates correlated with an
abundance of thin neovessels (p  0.01) and hsp60 gene expression (p  0.01), whereas
neoangiogenesis correlated with inflammation (p 0.04), calcium (p 0.01), and hsp60 gene
expression (p  0.04).
CONCLUSIONS “Degenerative” aortic valve stenosis appears to be a chronic inflammatory process associated
with atherosclerotic risk factors. The coexistence of neoangiogenesis, T-lymphocyte infiltra-
tion, adhesion molecules, and hsp60 gene expression indicates an active immunomediated
process in the final phases of the disease. (J Am Coll Cardiol 2004;43:1670–6) © 2004 by
the American College of Cardiology Foundationb
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conrheumatic aortic valve stenosis is the most common
alve disease in Europe and North America (1). Here, aortic
clerosis is present in about 26% of the population 65 years
f age and older, whereas stenosis is evident in 2% to 7% of
his age group (1). Calcified aortic valve stenosis increases in
revalence with age; it has a progressive course and is the
ost common reason for valve replacement (2). Several
tudies have demonstrated cardiovascular risk factors in
ommon with atherosclerosis, including hyperlipidemia,
ypertension, and diabetes (1,3,4), and similar pathological
eatures, including endothelial damage, lipid deposition,
nd inflammatory infiltrates, making early aortic valve
esions appear similar to atheromas (5–7). Further evidence
xists that progressive calcified aortic stenosis is an “active”
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he Center of Excellence on Aging at the “G. d’Annunzio” University, Chieti, Italy.
Manuscript received May 30, 2003; revised manuscript received November 26,e003, accepted December 1, 2003.iological process, similar to vascular calcification (8), sus-
ained by mechanical stress and inflammation, and associ-
ted with the synthesis of extracellular matrix proteins, such
s metalloproteinases (9), tenascin-C (10), osteopontin (11),
nd bone sialoprotein (12).
More recently, heterotopic ossification, associated with
nflammation and neoangiogenesis, has been described,
uggesting an unexpected process of tissue repair in end-
tage calcified heart valves (12). On the basis of a previous
tudy (7), we hypothesized that chronic valve inflammation
s triggered by local injury and sustained by a cellular
mmune response mediated by heat shock proteins, acti-
ated T-lymphocytes, and adhesion molecules. These events
re similar to those occurring in atherosclerotic lesions
13,14), where inflammatory infiltrates, neoangiogenesis,
nd endothelial activation represent a route for leukocyte
ecruitment and tissue infiltration, thus maintaining a
hronic, inflammation-promoting plaque evolution (15,16).
In this study we investigated inflammatory features in
nd-stage aortic valve lesions from human surgical samples,
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May 5, 2004:1670–6 Biological Features of Aortic Valve Stenosissing histological, immunohistochemical, and molecular
iology procedures. We also measured and compared sys-
emic lipid and inflammatory markers in these patients and
n a control group.
ETHODS
e examined specimens of aortic valve leaflets obtained
rom 26 patients who had undergone aortic valve replace-
ent for calcified aortic stenosis (group A), and 14 nonste-
otic aortic valve samples as controls (group B). The control
ases were collected from surgical patients affected by aortic
Abbreviations and Acronyms
CRP  C-reactive protein
DNA  deoxyribonucleic acid
ESR  erythrocyte sedimentation rate
GAPDH  glyceraldehyde-3-phosphate dehydrogenase
HE  hematoxylin-eosin
hsp60  heat shock protein-60
ICAM-1  intercellular adhesion molecule-1
LDL  low-density lipoprotein
mRNA  messenger ribonucleic acid
PBS  phosphate-buffered saline
PCR  polymerase chain reaction
RT  reverse transcription
VCAM-1  vascular cell adhesion molecule-1
WVG  Weigert-van Gieson
Table 1. Demographic and Clinical Data of Sur
Number
Age (yrs) (mean  SD)
Gender (M/F)
Smokers
Hypertension
Diabetes
Duration of symptoms (months)
Coronary artery disease
Clinical coronary heart disease
Carotid atherosclerosis
Clinical cerebrovascular disease
Peripheral arterial disease
Angina
Dyspnea
Syncope
Hypertriglyceridemia (150 mg/dl)
Hypercholesterolemia (200 mg/dl)
LDL cholesterol 100 mg/dl
LDL cholesterol (mg/dl) (mean  SD)
HDL cholesterol (mg/dl) (mean  SD)
Triglycerides (mg/dl) (mean  SD)
Total cholesterol (mg/dl) (mean  SD)
Erythrocyte sedimentation rate (mm/h)
C-reactive protein (mg/dl) (mean  SD)
Fibrinogen (mg/dl) (mean  SD)
Valvular area (cm2) (mean  SD)
Mean transvalvular gradient (mm Hg) (mean  SD)
Left ventricular ejection fraction (mean  SD)
Ascending aorta diameter (mean  SD)HDL  high-density lipoprotein; LDL  low-density lipoproteinalve insufficiency due to aneurysms on the ascending aorta,
ith a diagnosis based on preoperative Doppler echocardi-
graphy, cardiac catheterization, or both. Relevant clinical
ata from patients are listed in Table 1.
Diagnosis of aortic valve stenosis was confirmed on inspec-
ion of the valve during surgery. To ensure that leaflets
btained were representative of the entire valve and of non-
heumatic aortic stenosis, exclusion criteria were: 1) any evi-
ence of postrheumatic endocarditis, and 2) significant aortic
egurgitation or other coexistent valvular disease, with the
xception of calcifications of the mitral ring. The research
rotocol was approved by the local ethics committee.
istological analysis. All samples were fixed in 10% buff-
red formalin for 24 h, decalcified overnight with formic
cid, and processed for routine paraffin embedding. Valve
amples were excised vertically through the valve cusps near
he center of each leaflet. Sections 5-m-thick were ob-
ained from paraffin-embedded samples and stained with
oth hematoxylin-eosin (HE) and Weigert-van Gieson
WVG).
Histological sections were analyzed semiquantitatively
ccording to the following scoring system: for inflammatory
ells (0, 1, 2, 3: absence, minimal infiltrates, infiltrates
resent in aggregates, or widespread infiltrates, respec-
ively); for sclerosis (0, 1, 2, 3: absence, some pres-
nce, predominant, and complete, respectively); for calcium
0, 1, 2, 3: absence, isolated areas, multiple areas with
Patients Undergoing Aortic Valve Replacement
Group A Group B p Value
26 14
71.6  5.2 65.4  4 0.001
15/11 12/2 0.075
16/26 2/14 0.004
20/26 7/14 0.083
3/26 1/14 0.709
35.8  39.2 17.5  14 0.495
11/26 4/14 0.279
8/26 1/14 0.088
24/26 2/14  0.0001
5/26 0/14 0.186
3/26 0/14 0.186
11/26 1/14 0.021
23/26 9/14 0.068
7/26 0/14 0.033
3/26 2/14 0.876
15/26 3/14 0.014
20/26 4/14 0.001
132.7  34.2 94.7  21.4 0.001
60  10.2 55.5  18.2 0.310
136.6  62.2 112  54.6 0.164
223.8  46.4 166.2  34  0.0001
33.4  26.7 11  2.7  0.0001
17  20 4  1.3 0.010
550.6  182.3 339  76  0.0001
0.69  0.15 — —
57  14 — —
52  10 51.9  6.3 0.633
36  4 49  8  0.0001gical.
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Biological Features of Aortic Valve Stenosis May 5, 2004:1670–6arge amounts of calcium, or widespread infiltration, respec-
ively); and for neoangiogenesis (0, 1, 2, 3: absence,
solated neovessels, minimal aggregates, or abundant
eovessels, respectively).
mmunohistochemical analysis. Immunohistochemical
nalysis was performed on all samples to detect lymphocytes
LCA; DAKO, Denmark; dilution 1:400), T-lymphocytes
UCHL1; DAKO; dilution 1:200), vascular cell adhesion
olecule-1 (VCAM-1) (CD106; Novocastra Laboratories,
nited Kingdom; dilution 1:75), and intercellular adhesion
olecule-1 (ICAM-1) (CD54; Novocastra Laboratories;
ilution 1:25). Sections mounted on slides were blocked
ith 3% H2O2, washed with phosphate-buffered saline
PBS), incubated for 60 min with the primary antibody, and
ewashed with PBS. A biotin-labeled secondary antibody
as applied for 30 min, followed by a streptavidin-biotin-
eroxidase conjugate (ABC Elite, Vector Laboratories,
urlingame, California). A standard peroxidase enzyme
ubstrate, 3,3-diaminobenzidine, was used to yield a black
eaction product. Sections were counterstained with hema-
oxylin. The expression of VCAM-1 and ICAM-1 was
raded on a semiquantitative scale, ranging from 0 (no
xpression) to 3 (most intense expression).
emiquantitative reverse transcription (RT)–polymerase
hain reaction (PCR). We detected the expression of heat
hock protein 60 (hsp60) by a semiquantitative evaluation of
ts specific messenger ribonucleic acid (mRNA). We exam-
ned samples of both aortic degenerative valves and control
amples for hsp60 mRNA. One leaflet from each sample was
mmediately frozen in liquid nitrogen and stored at 80°C;
otal RNA was extracted using the Tripure Isolation Re-
gent (Roche Molecular Biochemical, Mannheim, Ger-
any) following the manufacturer’s instructions (17). To
void the contamination of genomic deoxyribonucleic acid
DNA), the RNA was treated with DNase RQ1 (Promega,
adison, Wisconsin); 300 ng were used for RT, using
ligo(dT)12–18 (Pharmacia, Uppsala, Sweden). Both RNasin
nd M-MLV RT were obtained from Promega (Madison,
isconsin). The RT was performed at 42°C for 1 h. To
erify the absence of DNA contamination, a parallel reac-
ion without RT was performed as a control. The house-
eeping gene glyceraldehyde-3-phosphate dehydrogenase
GAPDH) (reference gene) was co-amplified with the
sp60 target gene, in a multiplex PCR using two couples of
pecific primers (17). The PCR products were separated on
6% polyacrylamide gel and silver-stained. The density of
he GAPDH and hsp60 bands were analyzed using the
ational Institutes of Health Image 1.60 program.
erum lipids and inflammatory markers. Peripheral ve-
ous blood was assayed for total cholesterol, triglycerides,
igh-density lipoprotein cholesterol (using an enzymatic
emporized end point method), low-density lipoprotein
LDL) cholesterol (calculated by Friedewald’s equation),
rythrocyte sedimentation rate (ESR) (using Westergren’s
ethod), C-reactive protein (CRP) (using a high-sensitivity dpectrophotometric method), and fibrinogen (using a coag-
lation method).
tatistical analysis. For comparisons between groups the
onparametric Kruskal-Wallis test was used for quantitative
arameters and the chi-square test in contingency tables for
ualitative parameters. Pearson’s correlation coefficient was
sed to evaluate links between quantitative variables. Sta-
istical significance was set at p  0.05.
ESULTS
linical findings. The clinical findings in patients affected
y degenerative aortic valve stenosis differed from control
atients in some atherosclerosis risk factors, as summarized
n Table 1.
acroscopic findings. All aortic valves examined were
ricuspid. Macroscopically, they were noticeably thickened,
rregular, and showed multiple, contiguous nodules extend-
ng from the base toward the middle portion, with preserved
ommissures. The control valve group appeared normal,
ith only slight thickening of the leaflets.
ight microscopy analysis. At HE and WVG staining, we
ound large amounts of calcification in a nodular form in
lmost all samples (25 of 26) (Fig. 1a), and dense fibrosis in
ll of them. In 3 of 26 aortic valve samples we observed
artilage tissue with chondrocytes and areas of ossification,
ith bone marrow structure (Fig. 1b). Inflammatory infil-
rates were present in almost all samples (25 of 26) in small
ggregate areas around substantial calcium deposits, or
iffused throughout the leaflets, on the aortic or ventricular
ide of the subendothelial layers. The T-lymphocytes were
he most predominant cells in these infiltrates, but mono-
ytes and plasma cells were also present. A correlation was
ound between valve inflammation and duration of symp-
oms (chi-square  4.227; p  0.04). All control samples
ppeared negative for neoangiogenesis, inflammatory infil-
rates, and calcium deposits, consistent with the notion that
alve cusps in noninflamed conditions are nonvascular
issues, sufficiently thin to allow complete nutrition by
iffusion (Fig. 1c).
Neoangiogenesis was evident in 85% (22 of 26) of aortic
alve leaflets examined, with a larger number of neovessels
n areas where inflammatory infiltrates were more dense
2 or 3). We observed a high number of neovessels with
hin walls (thickness 10 m) (Fig. 2a) in areas rich in
ymphocyte infiltrates, and neovessels with thick walls
thickness30 m) in both inflammatory and fibrotic areas
Fig. 2b). Correlations were found between total neoangio-
enesis and amounts of inflammatory cells (chi-square 
.129; p  0.042); between neoangiogenesis and calcium
chi-square  5.643; p  0.01); and between thin vessel
alls and abundance of inflammatory cells (chi-square 
.686; p  0.01).
mmunohistochemistry. Endothelial cells of neovessels
ere positive for ICAM-1 and VCAM-1, with different
egrees of expression (Figs. 2c and 2d), whereas only
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ndothelial activation was co-localized with inflammatory
nfiltrates. A lesser degree of adhesion molecule expression
as evident on endothelial valve surfaces. A positive corre-
ation was found between ICAM-1 expression and calcium
eposits (chi-square  6.232; p  0.044). In control
amples of aortic valves, adhesion molecule expression was
egative.
xpression of hsp60. In group A, hsp60 mRNA expression
as present at a variable degree of 0.22- to 1.13-fold from
he constitutively expressed GAPDH gene (Fig. 3). We
ound that hsp60 gene expression is correlated to neo-
ngiogenesis (chi-square  4.267; p  0.03) and to
-lymphocyte inflammatory infiltrates (chi-square 5.745;
 0.01). In group B, hsp60 mRNA expression proved
ositive in 2 of 14 of the samples examined.
erum lipid and inflammatory markers. Serum lipid and
nflammatory markers were evaluated in the group of cases
group A) and in the surgical controls (group B), with
tatistical significance (Table 1). No correlation was found
etween abundance of inflammatory infiltrates and systemic
igure 1. (a) The majority of calcified stenotic valves studied, as in this ca
ase 12: areas with ossification and bone marrow formation were observed
ontrol patient showing slight thickening and fibrosis of the valve leaflet (nflammatory markers. iISCUSSION
alve tissue findings. Our main finding is evidence that an
ctive inflammatory process, sustained by neoangiogenesis,
ccurs in “degenerative” aortic valve stenosis. Inflammatory
nfiltrates in fibrotic areas are localized around large nodular
alcium deposits, the most prominent component of ad-
anced lesions. Inflammatory infiltrates are characterized by
bundant T-lymphocytes and neovessels. Calcium deposits,
eoangiogenesis, and inflammation appear to be relevant
iological features in the final stage of calcified valve lesions
n comparison to the early phase of aortic disease, where
holesterol, lipoproteins, and macrophages are prevalent in
elation to T-lymphocytes and tissue mineralization (5,6).
n contrast, in our control samples, inflammatory cells and
eovessels are absent. Thick neovessel walls are associated
ith fibrosis and sparse inflammatory cells, whereas thin
eovessel walls are localized in areas with a prevalence of
-lymphocyte infiltration, showing a significant correlation
ith the latter. The activated endothelium, expressing
CAM-1 and ICAM-1, represents the main route for
issue leukocyte infiltration and for a self-perpetuating
occupied by calcium deposits (violet area, hematoxylin-eosin [HE]). (b)
calcified aortic valve leaflet (HE). (c) Sample of normal aortic valve fromse, are
in a
HE).nflammatory process (18).
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Biological Features of Aortic Valve Stenosis May 5, 2004:1670–6In our study, the correlation between neoangiogenesis
nd calcium deposits supports the hypothesis that calcifica-
ion is an active process sustained by neoangiogenesis and
ascular endothelial growth factors, rather than a passive
rocess of dystrophic calcification into degenerating con-
ective tissue (10,11). Moreover, three valve samples in-
luded endochondral and bone tissue associated with bone
arrow, showing neoangiogenesis and activated endothe-
ium in percentages similar to those identified by Mohler et
l. (12). We demonstrated hsp60 gene expression in all
alcified stenotic valves, correlating both with inflammatory
nfiltrates and with neoangiogenesis. Heat shock proteins
re expressed by cells under stress conditions (such as
nflammation induced by cholesterol and triglyceride-
ontaining lipoprotein particles, viral or bacterial antigen
xposure, shear or mechanical stress) (14,19,20). In 2 of 14
ases of control valves, hsp60 gene expression suggests that
t may be primarily generated within the cells as a response
o a mechanical injury in degenerative aortic valve disease
14). In contrast, in calcified aortic valves, the process
robably begins with endothelial damage induced by known
igure 2. (a) In a calcified aortic valve, abundant inflammatory infiltra
-lymphocytes, plasma cells, and macrophages (hematoxylin-eosin [HE]).
rea devoid of inflammatory infiltrates (HE). (c, d) Immunohistochemic
dhesion molecule-1 (VCAM-1) (stained dark brown) is observed in thetes are observed with small thin-walled neovessels, prevalently composed of
(b) In a calcified aortic valve, thick-walled neovessels are observed in a fibrotic
al positivity for intercellular adhesion molecule-1 (ICAM-1) and vascular cell
endothelial cells of thin-walled neovessels 3,3-diaminobenzidine.isk factors, which leads to hsp60 cellular expression and Digure 3. Gel electrophoresis of two samples from patients with calcified
ortic valve disease (Cases 13 and 19) after reverse transcription (RT)-
olymerase chain reaction. Both glyceraldehyde-3-phosphate dehydroge-
ase (GAPDH) and heat shock protein-60 (hsp60) indicate their respective
mplification products. In the “No RT” lane, retrotranscription after the
Nase treatment of the samples was omitted.
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May 5, 2004:1670–6 Biological Features of Aortic Valve Stenosisubsequent triggering of an autoimmune reaction against
ocal antigens, culminating in stenotic valve disease.
omparison with previous published reports. Many in-
estigators agree that valve calcification is an active inflam-
atory process. Collagen (tenascin-C) or bone matrix
roteins (osteopontin and osteonectin) produced by acti-
ated macrophages and vascular cells (10,21) promote neo-
ngiogenesis (22) and are involved in the regulation of
alcium deposition in atherosclerotic plaques (21–23), as
ell as in cardiac valves (10). In contrast, Mohler et al. (12)
uggest that dystrophic calcification is a passive degenera-
ion of connective tissue, whereas heterotopic ossification is
n active process of abnormal tissue repair. Our study shows
o difference in the correlation between calcium deposits
nd neoangiogenesis either in calcified or in ossified valve
amples. Conversely, the existing correlations among calci-
cation, neoangiogenesis, inflammation, and hsp60 gene
xpression, as well as that between neoangiogenesis and
nflammation, or neoangiogenesis and calcium, support the
ypothesis that global valve mineralization is a biologically
ctive process.
The coexistence of biological features such as tissue
ineralization, high prevalence of T-lymphocyte infiltra-
ion, neoangiogenesis, endothelial activation, and hsp60
ene expression may be indicative of a cell-mediated im-
une mechanism, as previously suggested for the develop-
ent of atherosclerotic plaques (13,14). The demonstration
f T-lymphocyte activation, by detection of interleukin-2
eceptor expression in nonrheumatic aortic valve stenosis
7), suggests that an immune reaction against local antigens
ay be a pathogenic factor for valve calcification and
tenosis. No data are currently available showing the coex-
stence of T-lymphocyte infiltration, neoangiogenesis, en-
othelial activation, and hsp60 gene expression as hallmarks
f an immunomediated inflammatory process in the end-
tage of aortic stenosis. In these advanced phases of the
isease, abnormal rheology and mechanical stress overload,
xacerbated by loss of aortic wall compliance in elderly
atients, may induce additional changes in the microstruc-
ure of the aortic leaflet (24).
linical and biohumoral features. In this study, patients
ith calcified aortic valve stenosis frequently exhibited risk
actors for atherosclerosis such as smoking and hypercho-
esterolemia. Systemic hypertension was present in 80% of
roup A patients and 50% of group B patients. In the latter,
ypertension alone appeared insufficient to induce a visible
nflammatory tissue response. Moreover, group A patients
howed high serum levels of total and LDL cholesterol, and
f inflammatory markers such as ESR, CRP, and fibrino-
en, compared to group B.
omparison with the published data. Risk factors for
therosclerosis are probably pathogenetically involved in
arly valve lesions by inducing endothelial injury (4–6).
ecent data by Poggianti et al. (25) demonstrate an associ-
tion between aortic valve sclerosis and systemic endothelial
ysfunction. We confirmed a correlation among smoking,arotid atherosclerosis, hypercholesterolemia, and high se-
um LDL cholesterol levels on the one hand, and calcified
ortic valve stenosis on the other. Further studies also
ighlight a new role for modified serum lipoproteins and
ascular smooth muscle cells in the development of calcifi-
ation in atherosclerosis.
Deposition of oxidized LDL in the artery wall increases
onocyte-induced vascular calcification (26), stimulates
alcification by enhancing osteogenic differentiation of vas-
ular smooth muscle cells (27), and influences the progres-
ion of valve calcification and stenosis (28). Similar to
therosclerotic vascular disease, previous studies have shown
ncreased plasma levels of CRP (29) and ICAM-1 (18),
ystemic markers of inflammation in patients with degen-
rative aortic valve stenosis. In agreement with Galante et
l. (29), CRP plasma levels in patients with calcified valve
tenosis are higher, together with ESR and fibrinogen.
oreover, by ultrasound and catheterization we found
vidence of diffuse atherosclerotic disease (involving the
arotids, and coronary and peripheral arteries) in the same
atients, which might further explain the increase of sys-
emic inflammatory markers. This issue requires additional
valuation to confirm whether atherogenesis may indeed be
onsidered an extensive chronic inflammatory process (30).
tudy limitations. Limitations to our study lie in the
bjective difficulties of: 1) analyzing the progression from
clerosis to end-stage aortic valve lesions in order to support
ur research into similar characteristics between atheroscle-
osis and aortic valve disease and 2) the lack of surgical
atients with similar age, lipid levels, and other risk factors
or atherosclerosis without aortic valvular disease, to form an
deal control group.
onclusions. The end-stage of nonrheumatic aortic valve
tenosis, characterized by the high prevalence of tissue
ineralization, shows some biological features of an active
nflammatory process. The co-existence of T-lymphocytes
nd neoangiogenesis, adhesion molecule expression in en-
othelial and inflammatory cells, and hsp60 gene expression
s indicative of a chronic, active immunomediated process.
nflammation and progression of mineralization appear to
e sustained by a constant angiogenetic process. The pres-
nce of local and systemic inflammation in patients with
egenerative aortic valve stenosis, and the similarities of risk
actors for atherosclerosis, reinforce the hypothesis that a
ommon inflammatory process is involved in valvular dis-
ase and atherosclerosis.
cknowledgments
he authors thank Laura Ramberti (technical assistance)
nd Emma Thorley (editorial help).
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one, Department of Cardiology and Cardiac Surgery, Ospedale
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